interferoninduc
transmembran
protein
ifitm
famili
highli
relat
protein
present
two
transmembran
domain
tm
connect
short
linker
region
n
ctermini
variabl
length
human
famili
compos
five
express
member
bona
fide
interferonregul
gene
mainli
express
bone
tissu
genet
link
osteogenesi
imperfecta
remain
poorli
character
follow
initi
identif
antivir
modul
influenza
viru
infect
function
genom
screen
sever
studi
concur
establish
hereaft
refer
ifitm
key
compon
cellular
innat
defens
larg
antivir
spectrum
act
influenza
viru
filovirus
coronavirus
hiv
etc
first
studi
mechan
ifitm
interfer
viral
replic
take
place
target
cell
set
ifitm
sequest
incom
virion
particl
endosom
prevent
viraltocellular
membran
fusion
phenomenon
first
imped
access
viru
cell
cytoplasm
subsequ
lead
degrad
interest
note
mechan
inhibit
albeit
efficaci
depend
ifitm
viru
consid
target
virus
passag
acid
ph
endosom
mandatori
trigger
viraltocellular
membran
fusion
well
passag
obligatori
studi
concur
indic
strong
effect
ifitm
fusogen
properti
membran
precis
phase
affect
ifitm
remain
debat
given
ifitm
describ
block
hemifus
process
wherebi
outer
inner
leaflet
viral
cellular
membran
merg
transit
hemifus
pore
format
similarli
exact
molecular
mechan
ifitm
modifi
biophys
properti
membran
remain
unclear
controversi
link
past
chang
membran
cholesterol
level
recent
interact
cellular
cofactor
case
laboratori
togeth
other
recent
describ
addit
mechan
ifitm
coalesc
structur
protein
gag
virion
assembl
incorpor
newlyproduc
particl
display
reduc
infect
compar
wt
counterpart
due
decreas
abil
fuse
cellular
membran
novel
antivir
effect
refer
neg
imprint
viral
particl
infect
independ
cell
type
virus
produc
observ
establish
cell
line
primari
cell
target
replic
cell
macrophag
altogeth
data
along
data
literatur
suggest
least
case
ifitm
bear
abil
inhibit
viru
life
cycl
two
distinct
moment
viral
entri
target
cell
step
ifitm
interven
trap
incom
virion
endosom
vesicl
ii
virion
particl
assembl
phase
presenc
ifitm
lead
product
virion
reduc
infect
howev
although
former
antivir
properti
ifitm
firmli
establish
target
broad
rang
virus
entir
unappreci
whether
second
restrict
hiv
whether
appli
virus
address
question
examin
fourteen
differ
virus
encompass
wide
spectrum
viral
famili
divers
mode
replic
particular
negativestrand
rna
virus
vesicular
stomat
viru
vsv
measl
viru
mev
ebolaviru
ebov
dugb
viru
dugv
rift
valley
fever
viru
rvfv
mopeia
viru
mopv
positivestrand
rna
virus
west
nile
viru
wnv
hepat
c
viru
hcv
retrovirus
simian
immunodefici
viru
macaqu
sivmac
murin
leukemia
viru
mlv
masonpf
monkey
viru
mpmv
comparison
alreadi
describ
dna
virus
epsteinbarr
viru
ebv
adenoassoci
viru
aav
first
time
show
ifitm
reduc
infect
newli
produc
virion
particl
deriv
larg
spectrum
virus
well
beyond
addit
highlight
virus
either
fulli
resist
ifitm
hcv
rvfv
mopv
along
aav
display
exquisit
ifitm
memberspecif
suscept
dugv
ebv
heterogen
behavior
allow
us
use
genet
element
swap
ifitmresist
virus
point
specif
mode
virion
assembl
rather
viral
glycoprotein
domin
factor
suscept
toward
ifitm
howev
agreement
recent
studi
literatur
also
show
contrarili
strain
becom
resist
like
underli
novel
role
coreceptor
interplay
hiv
ifitm
final
reexamin
effect
play
ifitm
spread
infect
reveal
mechanist
due
concurr
action
exert
ifitm
target
cell
protect
product
virion
reduc
infect
knowledg
provid
first
exampl
antivir
factor
capabl
target
extrem
viru
life
cycl
assess
degre
conserv
ifitmmedi
neg
imprint
virion
particl
infect
examin
panel
fourteen
virus
span
famili
distinct
term
genom
replic
interact
cellular
host
interestingli
present
differ
mode
virion
assembl
schemat
present
fig
list
includ
sever
member
retrovirida
famili
particular
mlv
genu
gammaretroviru
mpmv
genu
betaretroviru
well
sivmac
genu
lentiviru
latter
previous
character
respect
suscept
ifitm
plusstrand
rna
flavivirida
wnv
genu
flaviviru
hcv
genu
hepaciviru
repres
member
differ
minusstrand
rna
viru
famili
rhabdovirida
vsv
paramyxovirida
mev
filovirida
ebov
well
segment
rna
virus
belong
bunyavirida
dugv
genu
nairoviru
rvfv
genu
phleboviru
arenavirida
mopv
complet
analysi
two
dna
virus
respect
member
herpesvirida
ebv
parvovirida
famili
aav
also
includ
contrarili
virus
examin
studi
aav
nonenvelop
viru
minim
inevit
variat
dictat
specif
one
virus
cellular
tropism
avail
clone
genom
viralcod
report
forth
decid
use
much
possibl
homogen
setup
assess
abil
interfer
product
infecti
virion
schemat
present
fig
specif
detail
supplementari
fig
ifitm
express
virusproduc
cell
condit
amount
compar
measur
primari
monocytederiv
dendrit
cell
mddc
stimul
type
ifn
supplementari
fig
previous
employ
reveal
novel
antivir
mechan
context
due
cell
type
specif
transfect
rate
intracellular
level
ifitm
measur
upon
transient
dna
transfect
vari
among
cell
line
although
variat
contain
within
fourfold
term
number
ifitmposit
cell
median
fluoresc
intens
mfi
measur
flow
cytometri
supplementari
fig
clone
viral
genom
allow
effici
viral
rescu
upon
dna
transfect
avail
virion
particl
produc
simpl
cotransfect
viral
compon
along
dna
code
ifitm
sivmac
mlv
mpmv
wnv
aav
otherwis
cell
transfect
individu
ifitm
infect
shortli
transfect
obtain
consist
pool
virusproduc
ifitmsexpress
cell
viral
particl
newlyproduc
cell
free
supernat
isol
purifi
ultracentrifug
sucros
cushion
wv
normal
protein
genom
content
supplement
fig
normal
amount
virion
particl
produc
presenc
absenc
ifitm
analyz
wb
use
challeng
target
cell
measur
infect
possibl
effect
ifitm
paramet
supplementari
fig
comprehens
comparison
infecti
titer
use
modif
use
adapt
specif
viru
featur
hone
cell
bear
latent
ebv
genom
carri
gfp
transfect
ifitm
code
dna
along
express
vector
code
viral
transcript
factor
stimul
viral
reactiv
virion
assembl
given
assembl
nucleu
aav
virion
purifi
cell
lysat
use
wellestablish
procedur
includ
freezethaw
cycl
virion
purif
step
gradient
iodixanol
hcv
ifitm
express
hepatocyt
cell
circumv
poor
transfect
rate
cell
express
ifitm
obtain
retroviralmedi
transduct
final
parent
virus
examin
case
vector
use
retrovirus
allow
us
pseudotyp
retrovir
particl
heterolog
envelop
vsv
g
protein
vsvg
better
appreci
potenti
subtler
differ
due
distinct
virion
assembl
mode
exist
retrovirida
vsvg
pseudotyp
commonli
use
studi
retrovirus
previous
determin
ifitm
exert
similar
defect
infect
viral
particl
bear
vsvg
gibbon
ape
leukemia
viru
galv
felin
leukemia
viru
envelop
protein
condit
describ
use
presenc
ifitm
virusproduc
cell
appreci
modifi
amount
virion
particl
produc
although
trend
toward
increas
viral
product
observ
aav
ebv
mopv
presenc
neg
one
observ
mlv
hcv
supplementari
fig
focu
intrins
infect
subsequ
assay
perform
viru
normal
virion
particl
produc
presenc
absenc
ifitm
next
abil
ifitm
incorpor
cofraction
normal
viral
prepar
assess
western
blot
fig
line
nonenvelop
characterist
viral
prepar
aav
devoid
ifitm
even
four
time
start
materi
one
use
virus
use
fig
contrari
readili
detect
amount
observ
viral
fraction
envelop
virus
test
experiment
condit
use
uniqu
except
repres
dugv
undetect
viral
prepar
contrarili
despit
compar
intracellular
express
level
result
due
lower
viral
input
similar
amount
physic
dugv
particl
analyz
virus
exampl
mopv
rvfv
supplementari
fig
overal
data
present
fourteen
differ
virus
indic
ifitm
cofraction
envelop
virion
particl
robust
manner
direct
interact
env
ifitm
hypothes
drive
function
alter
amount
envelop
spike
present
virion
particl
although
find
confirm
studi
includ
given
discrep
import
determin
whether
ifitm
could
modifi
extent
matur
glycoprotein
incorpor
case
virus
end
examin
extent
matur
glycoprotein
incorpor
virion
particl
deriv
virus
antibodi
avail
fig
specif
defect
matur
glycoprotein
incorpor
virion
observ
presenc
ifitm
irrespect
glycoprotein
intracellular
processingmatur
pathway
schemat
display
right
panel
fig
refut
hypothesi
gener
mechan
ifitm
may
interact
andor
modifi
viral
glycoprotein
matur
incorpor
virion
two
consider
also
drawn
comparison
migrat
pattern
observ
differ
ifitm
sdspage
gel
analysi
first
protein
cell
hcv
panel
migrat
distinct
appar
molecular
weight
contrarili
ifitm
express
cell
type
reason
differ
unclear
although
pattern
equal
present
literatur
indistinctli
link
antivir
phenotyp
second
slower
migrat
form
ifitm
especi
case
observ
cellular
viral
fraction
band
observ
present
ident
unknown
although
specul
may
repres
post
translat
modif
ifitm
find
form
appear
concentr
viral
prepar
virus
may
suggest
select
enrich
site
virion
assembl
hypothesi
requir
studi
confirm
virion
associ
ifitm
sever
virus
produc
presenc
absenc
subject
immunogold
em
use
antibodi
specif
ntermin
flag
tag
virion
label
conduct
fresh
viral
prepar
prior
fixat
condit
yield
reproduc
result
hand
condit
detect
virion
test
sivmac
mlv
mpmv
vsv
mev
ebv
fig
quantit
analysi
number
gold
bead
per
virion
particl
due
technic
limit
constraint
andor
limit
avail
viral
materi
analysi
could
carri
remain
virus
overal
data
show
associ
capsidcontain
virion
particl
deriv
differ
virus
clearli
support
notion
ifitm
inde
incorpor
virion
although
exclud
possibl
portion
virionassoci
ifitm
may
deriv
nonvirion
associ
materi
next
impact
ifitm
infect
virion
particl
determin
infect
cell
normal
amount
virion
fig
expect
ifitm
decreas
infect
sivmac
virion
particl
infect
mlv
mpmv
also
affect
albeit
moder
case
mpmv
three
ifitm
mlv
specif
fig
result
intrigu
mlv
especi
mpmv
display
assembl
specif
distinct
lentivirus
although
ultim
acquir
plasma
membranederiv
envelop
viral
infect
also
significantli
impair
case
vsv
mev
ebov
wnv
major
differ
among
ifitm
member
instead
dugv
ebv
display
member
specif
suscept
ifitm
particular
infect
dugv
impair
small
statist
signific
extent
ebv
display
reciproc
suscept
lastli
infect
hcv
rvfv
mopv
aav
virion
unaffect
ifitm
ntermin
tag
ifitm
protein
wide
use
field
howev
import
ascertain
presenc
tag
respons
antivir
effect
ascrib
ifitm
end
compar
effect
tag
nontag
ifitm
vsv
taken
extrem
virus
suscept
ifitm
condit
ifitm
configur
exert
similar
antivir
effect
therebi
exclud
artefactu
effect
due
presenc
tag
supplementari
fig
behavior
aav
surpris
given
nonenvelop
featur
resist
hcv
rvfv
mopv
could
principl
due
insuffici
level
express
ifitm
virusproduc
cell
believ
case
rvfv
mopv
aav
produc
cell
condit
similar
retrovirus
wnv
instead
suscept
ifitm
see
supplementari
fig
comparison
viral
system
use
similarli
ifitm
modifi
infect
hcv
particl
affect
one
vsv
test
supplementari
fig
therefor
believ
resist
phenotyp
describ
hcv
rvfv
mopv
aav
reflect
true
behavior
viru
rather
limit
amount
ifitm
virusproduc
cell
principl
lower
plasma
membran
distribut
could
predict
induc
moder
infect
defect
virus
assembl
locat
compar
howev
cell
surfac
stain
nonpermabil
cell
supplementari
fig
indic
clearli
present
detect
level
plasma
membran
suggest
membran
dynam
may
contribut
flatten
differ
individu
ifitm
member
term
access
viral
assembl
site
antivir
effect
ifitm
shown
incorpor
virion
particl
virus
studi
also
found
present
exosom
exclud
possibl
influenc
exosomalassoci
ifitm
protein
infect
assay
took
advantag
previou
studi
identifi
cellular
protein
specif
exclud
virus
due
long
cytoplasm
tail
freeli
present
exosom
cell
stabli
express
infect
vsv
prolong
period
time
obtain
suffici
amount
releas
virion
particl
produc
presenc
ifitm
protein
viral
prepar
separ
two
either
subject
deplet
bead
remov
virion
purifi
ultracentrifug
upon
normal
analyz
wb
infect
fig
deplet
work
effici
laboratori
publish
case
virionassoci
ifitm
signal
persist
viral
fraction
even
deplet
result
howev
extend
previou
find
indic
even
case
vsv
ifitm
becom
essenti
virionassoci
cell
undergo
activ
viral
bud
infect
nondeplet
virion
analyz
differ
observ
therebi
exclud
possibl
confound
role
exosom
may
present
viral
prepar
assess
role
endogen
ifitm
silenc
three
ifitm
time
follow
shrnasmedi
lentiviralbas
transduct
establish
cell
line
hela
cell
primari
blood
cell
express
detect
level
even
prior
ifn
stimul
primari
blood
lymphocyt
pbl
monocytederiv
macrophag
ifnstimul
use
increas
level
express
ifitm
due
pleiotrop
effect
cell
physiolog
would
complic
analysi
result
obtain
knockdown
cell
challeng
indic
virus
newlyproduc
virion
particl
assembl
absenc
presenc
endogen
ifitm
purifi
normal
infect
assess
accord
scheme
provid
fig
case
ebov
infect
primari
macrophag
silenc
ifitm
viral
spread
could
analyz
due
limit
amount
materi
avail
absenc
viral
infect
endogen
ifitm
protein
detect
supernat
cell
use
fig
support
notion
major
secret
mode
ifitm
condit
incorpor
virion
also
evid
wb
panel
fig
expect
intracellular
reduct
ifitm
led
concomit
reduct
amount
virionassoci
ifitm
newlyproduc
virion
particl
normal
use
challeng
target
cell
infect
virion
produc
ifitmknockdown
cell
reproduc
increas
three
virus
test
vsv
mev
latter
case
complet
analysi
alreadi
perform
primari
macrophag
thu
remov
endogen
ifitm
protein
result
increas
intrins
infect
virion
particl
corrobor
result
present
fig
case
ebov
silenc
ifitm
primari
macrophag
led
consist
increas
replic
capac
ebov
cell
cultur
fig
display
singl
time
point
complet
analysi
viral
spread
time
present
supplementari
fig
although
limit
materi
avail
preclud
purif
subsequ
analysi
infect
newlyproduc
virion
therefor
prevent
assign
dismiss
antivir
effect
ifitm
ebov
specif
mechan
issu
address
next
figur
overal
data
present
argu
two
import
point
endogen
ifitm
inde
incorpor
particl
issu
differ
virus
presenc
lead
de
facto
virion
particl
lower
infect
compar
virion
particl
produc
absenc
data
shown
indic
ifitm
interfer
infect
newli
produc
virion
particl
broad
manner
previous
report
abil
protect
target
cell
infect
howev
whether
two
mechan
coexist
spread
infect
extent
contribut
overal
antivir
properti
ifitm
unknown
address
issu
replic
compet
vsv
ebov
mev
wnv
virus
use
low
moi
challeng
doxinduc
cell
line
stabli
express
accord
scheme
present
fig
viral
spread
doxinduc
uninduc
cultur
measur
indic
time
point
post
infect
fig
expect
induct
reduc
spread
everi
viru
test
although
magnitud
reduct
vari
fig
quantifi
abil
protect
cell
incom
virus
cell
challeng
day
time
secondari
infect
remain
neglig
case
high
viral
dose
short
time
analysi
infect
cell
post
challeng
use
appreci
much
possibl
antivir
effect
singl
cycl
basi
fig
condit
expect
data
field
express
associ
statist
signific
protect
target
cell
fold
variabl
inhibit
rate
report
differ
virus
across
differ
studi
instanc
higher
describ
believ
differ
mainli
due
heterogen
experiment
system
use
cell
type
ifitm
express
level
use
pseudovirion
versu
replicationcompet
virus
time
analysi
etc
final
effect
play
product
infecti
virion
assess
harvest
cell
free
supernat
late
time
point
spread
infect
virion
particl
purifi
normal
infect
assess
target
cell
fig
use
high
viral
dose
short
time
analysi
challeng
fig
condit
virion
particl
produc
spread
infect
cell
cultur
express
display
reduc
infect
compar
virus
produc
absenc
fold
thu
confirm
differ
experiment
system
result
present
fig
first
time
result
present
indic
antivir
effect
play
viral
replic
result
abil
interfer
two
distinct
moment
viral
life
cycl
virus
divers
ebov
case
sever
studi
implic
envelop
glycoprotein
modul
viral
suscept
ifitm
particular
abil
engag
distinct
coreceptor
cell
entri
determin
whether
virion
assembl
mode
ident
glycoprotein
could
import
determin
antivir
effect
ifitm
test
heterolog
combin
core
glycoprotein
issu
suscept
resist
virus
assembl
presenc
absenc
ifitm
fig
end
pseudotyp
core
glycoprotein
hcv
system
develop
wide
use
field
studi
hcv
entri
addit
develop
studi
vsvbase
core
pseudotyp
gngc
glycoprotein
rvfv
cell
free
virion
particl
produc
presenc
absenc
ifitm
purifi
normal
either
analyz
wb
use
viral
challeng
prior
flow
cytometri
analysi
fig
experiment
condit
ifitm
well
incorpor
vsvbase
core
infect
virion
particl
determin
import
infect
defect
observ
vsv
core
bear
envelop
glycoprotein
hcv
rvfv
overal
result
strongli
suggest
viral
specif
mode
assembl
rather
specif
glycoprotein
repres
domin
factor
suscept
given
viru
ifitm
despit
fact
genet
swap
result
indic
viral
glycoprotein
domin
determin
factor
suscept
ifitm
sever
report
describ
envelop
protein
may
circumv
neg
effect
ifitm
accord
abil
use
either
coreceptor
molecul
particular
envelop
molecul
shown
display
near
complet
resist
determin
whether
case
introduc
retroviralmedi
gene
transduct
cell
use
fig
challeng
cell
follow
strain
contain
envelop
context
otherwis
provir
clone
three
transmit
founder
virus
obtain
singlegenom
amplif
four
virus
test
replic
well
irrespect
presenc
fig
virion
particl
produc
spread
infect
isol
normal
analyz
infect
singl
cycl
infect
basi
defect
observ
fig
result
thu
confirm
previou
report
respect
resist
virus
indic
abil
use
differ
entri
molecul
andor
entri
pathway
may
play
import
modulatori
role
suscept
differ
virus
toward
restrict
factor
ifitm
firmli
establish
broad
antivir
factor
act
mainli
sequestr
infect
virion
endosom
contrari
exist
addit
mechan
viral
interfer
ifitm
could
lead
format
virion
reduc
infect
previous
report
case
analyz
larg
panel
virus
establish
latter
refer
neg
imprint
virion
particl
infect
second
conserv
antivir
properti
ifitm
extend
well
beyond
hiv
target
differ
class
envelop
virus
first
time
reveal
antivir
mechan
concur
previous
describ
endosom
retent
particl
target
cell
overal
inhibit
ascrib
ifitm
viral
replic
therefor
result
present
studi
contribut
highlight
ifitm
novel
paradigm
restrict
factor
capabl
interf
extrem
viru
life
cycl
given
protect
offer
antivir
factor
often
incomplet
dual
mechan
inhibit
like
potenti
leverag
ifitm
viral
replic
despit
seem
larg
spectrum
viral
inhibit
analysi
also
highlight
exist
virus
resist
three
ifitm
member
test
hcv
rvfv
mopv
aav
well
virus
resist
given
member
suscept
other
ebv
dugv
indic
exist
certain
degre
heterogen
manner
virus
cope
ifitm
heterogen
surpris
larg
spectrum
behavior
previous
describ
literatur
respect
antivir
effect
play
ifitm
target
cell
worth
notic
comparison
effect
report
describ
literatur
fig
reveal
larg
concord
behavior
albeit
except
like
driven
heterogen
experiment
system
use
across
studi
virus
suscept
ifitm
target
cell
also
viral
particl
product
believ
concord
lend
support
previous
unappreci
notion
dual
inhibit
inde
gener
mechan
inhibit
orchestr
ifitm
initi
descript
determin
ifitm
incorpor
virion
particl
display
decreas
infect
remain
howev
unclear
whether
physic
incorpor
ifitm
virion
particl
requir
antivir
effect
whether
two
properti
dissoci
thorough
mutagen
studi
ifitm
protein
may
dissoci
two
properti
like
requir
formal
address
question
sever
line
evid
stem
compar
studi
support
notion
incorpor
ifitm
virion
inde
separ
antivir
effect
first
virion
packag
predict
antivir
effect
ifitm
ie
suffici
hcv
rvfv
mopv
well
ebv
dugv
case
specif
ifitm
member
display
detect
infect
defect
second
antivir
effect
observ
even
absenc
ifitm
incorpor
case
dugv
virion
produc
presenc
consider
lend
support
model
wherebi
ifitmpackag
ifitmmedi
imprint
viral
particl
least
case
uncoupl
suggest
imprint
effect
ifitm
take
place
cell
process
virion
particl
format
ifitm
membraneassoci
protein
therefor
presenc
exosom
addit
virion
particl
overal
surpris
experi
indic
howev
cell
undergo
virion
assembl
major
ifitm
protein
virionassoci
support
immunogold
em
result
exclud
de
facto
confound
role
contamin
exosom
infect
assay
studi
note
virus
assembl
exampl
plasma
membran
similarli
affect
three
ifitm
albeit
chang
magnitud
defect
observ
case
despit
report
differ
intracellular
distribut
among
ifitm
member
remain
possibl
experiment
setup
use
may
allow
us
fine
appreci
differ
individu
ifitm
member
result
indic
even
intern
distribut
ifitm
member
clearli
present
plasma
membran
nonpermeabil
cell
suggest
steadi
state
distribut
ifitm
protein
may
provid
limit
overview
like
instead
complic
process
inde
virion
assembl
membran
traffick
highli
dynam
process
associ
ifitm
membran
regul
intric
network
regulatori
modif
interact
cellular
cofactor
adaptor
protein
ligas
neural
precursor
cell
express
development
downregul
protein
fyn
light
consider
believ
complex
dynam
membran
traffick
like
facilit
encount
individu
ifitm
member
virus
assembl
differ
intracellular
locat
like
explain
result
obtain
heterogen
behavior
differ
virus
toward
ifitm
allow
us
provid
mechanist
insight
viral
determin
suscept
famili
restrict
factor
swap
genet
element
ifitmresist
suscept
virus
despit
intens
effort
viral
system
prove
amen
function
swap
use
previous
describ
pseudoparticl
system
base
hiv
core
incorpor
glycoprotein
develop
novel
one
base
vsv
core
packag
gngcrvfv
result
obtain
indic
mode
virion
assembl
intend
plethora
viral
protein
orchestr
product
novel
virion
particl
constitut
domin
determin
suscept
ifitm
respect
possibl
ifitmresist
virus
may
code
natur
antagonist
ifitm
high
potenti
interest
data
obtain
studi
seem
exclud
degradationbas
antagon
sinc
detect
deplet
ifitm
observ
either
cell
virionassoci
sampl
hcv
rvfv
mopv
virus
howev
antagon
establish
manner
instanc
induct
specif
posttransl
modif
affect
normal
antivir
behavior
ifitm
present
hypothesi
remain
interest
requir
experiment
work
despit
fact
result
exclud
viral
glycoprotein
modif
thereof
domin
factor
viral
behavior
toward
ifitm
recent
studi
describ
envelop
tropism
ie
abil
engag
coreceptor
modul
suscept
ifitm
case
reliev
inhibit
complet
result
obtain
virus
also
concur
conclus
indic
virus
resist
least
express
cell
present
remain
unclear
entri
rather
would
differ
drive
opposit
outcom
two
consider
may
help
complet
canva
first
coreceptor
usag
often
coupl
differ
affin
paramet
may
import
respect
behaviour
toward
ifitm
second
previou
studi
shown
endogen
ifitm
silenc
primari
macrophag
increas
infect
indic
coreceptor
usag
infect
outcom
may
also
fine
depend
cell
type
would
unpreced
instanc
primari
macrophag
resist
viru
infect
despit
presenc
appropri
coreceptor
taken
togeth
believ
result
indic
chang
coreceptor
usag
coupl
differ
affin
may
influenc
outcom
infect
respect
ifitm
cell
type
depend
manner
whether
occur
remain
determin
howev
experiment
observ
certainli
reveal
presenc
addit
layer
complex
relationship
hiv
ifitm
would
interest
explor
viral
set
measur
directli
due
lack
robust
viral
entri
system
virus
use
ifitm
alway
report
act
alter
fusogen
properti
cellular
viral
membran
opposit
counterpart
consid
viral
membran
ultim
deriv
cell
favor
hypothesi
accord
ifitm
act
use
singl
molecular
mechan
modifi
cellular
membran
yield
two
distinct
outcom
effect
target
cell
effect
newlyproduc
virion
much
known
molecular
mechan
ifitm
act
least
two
interest
cellular
protein
describ
potenti
involv
antivir
effect
vapa
key
regul
lipid
composit
cellular
membran
posit
ergolgi
interfac
recent
act
endoproteas
within
cell
role
cellular
cofactor
antivir
mechan
inhibit
ifitm
remain
wholli
elucid
easi
envis
modif
either
protein
lipid
composit
cellular
therefor
viral
membran
could
provid
broad
mechan
interfer
larg
spectrum
virus
hypothesi
correct
protect
provid
glycoprotein
env
may
due
increas
propens
acquir
fusionpron
conform
lower
requir
intramembran
movement
upon
engag
appropri
cellular
receptor
conclus
studi
indic
abil
ifitm
interfer
product
infecti
viral
particl
conserv
antivir
properti
ifitm
highlight
first
time
ifitm
restrict
factor
capabl
interf
viral
replic
two
distinct
moment
life
cycl
hela
vero
cell
obtain
cellulonet
repositori
sfrbioscienc
gerland
maintain
complet
dmem
media
supplement
fc
sigma
rpmi
media
cell
similarli
propag
obtain
laboratori
franci
v
chisari
scripp
research
institut
la
jolla
ca
usa
hone
cell
contain
latent
ebvgfp
genom
maintain
rpmi
verohslam
cell
express
human
receptor
slam
use
measl
viru
infectionsproduct
obtain
yusuk
yanagi
kyushu
univers
fukuoka
japan
cell
stabli
express
receptor
coreceptor
addit
integr
control
long
termin
repeat
promot
describ
peripher
blood
lymphocyt
pbl
obtain
ficol
gradient
purif
cell
maintain
rpmi
supplement
fc
prior
usag
pbl
activ
twentyfour
hour
phytohemagglutinin
pha
sigma
uml
interleukin
obtain
aid
reagent
refer
program
nih
monocyt
first
enrich
white
blood
leukocyt
success
ficol
percol
gradient
purifi
neg
deplet
monocyt
isol
kit
ii
catalogu
miltenyi
obtain
cell
popul
puriti
equalsuperior
monocyt
either
differenti
immatur
monocytederiv
dendrit
cell
mddc
incub
day
gmcsf
ngml
catalogu
eurobio
macrophag
upon
incub
ngml
mcsf
eurobio
catalogu
indic
mddc
incub
hour
uml
human
catalogu
tebu
bio
primari
blood
cell
obtain
blood
healthi
donor
efslyon
form
discard
leukopack
obtain
anonym
gender
race
age
donor
unknown
investig
inclus
women
minor
children
determin
research
exempt
approv
although
written
inform
consent
obtain
blood
donor
allow
use
cell
research
purpos
complet
overview
virus
viral
system
use
provid
supplementari
fig
tabl
antibodi
either
acquir
provid
describ
supplementari
tabl
follow
refer
ntermin
flagtag
code
dna
describ
untag
version
protein
obtain
standard
clone
techniqu
circumv
poor
transfect
rate
cell
retrovir
transduct
use
gener
cell
express
flagtag
ifitm
doxycyclineinduc
form
well
hcv
genotyp
express
plasmid
describ
respect
rvfv
gngc
code
sequenc
clone
context
phcmv
construct
use
standard
molecular
biolog
techniqu
retrovir
vector
code
human
obtain
aid
repositori
nih
indic
express
cell
obtain
retrovir
mediat
gene
transduct
antibodi
use
flow
cytometri
purchas
becton
dickinson
schemat
overview
present
supplementari
fig
case
virion
produc
presenceabs
ifitm
collect
hour
initi
viral
challeng
transient
transfect
indic
replic
experi
perform
construct
envelop
replac
correspond
one
tropic
strain
ada
transmit
founder
strain
wito
supplementari
tabl
infect
virion
particl
measur
case
report
cell
line
bear
coreceptor
gene
control
viral
ltr
virion
particl
pseudotyp
hcv
glycoprotein
describ
prepar
vsv
pseudotyp
cell
first
transfect
dna
express
rvfvgngc
ifitm
twentyfour
hour
later
cell
infect
viral
stock
replicationdefici
viru
previous
complement
vsvg
vsvg
reconstitut
allow
viral
entri
cell
express
vsv
genom
except
g
gene
allow
product
pseudoparticl
incorpor
glycoprotein
interest
one
hour
infect
residu
virus
neutral
incub
monoclon
antibodi
direct
vsvg
one
day
later
cell
supernat
collect
clarifi
centrifug
except
aav
see
cell
free
supernat
first
centrifug
low
speed
minut
syringefilt
virion
particl
purifi
ultracentrifug
sucros
cushion
wvol
two
hour
viral
pellet
resuspend
pb
analysi
sinc
aav
virion
assembl
insid
nucleu
cell
lyse
mm
nacl
mm
trishcl
ph
subject
round
freezethaw
liquid
nitrogen
robust
vortex
thaw
step
crude
lysat
clarifi
centrifug
minut
supernat
purifi
ultracentrifug
hour
iodixanol
fourstep
gradient
centrifug
aav
retriev
iodixanol
fraction
describ
cell
stabli
transduc
individu
doxinduc
ifitm
member
infect
cell
moi
week
cultur
vsv
cell
moi
day
cultur
end
cultur
period
virion
harvest
syringefilt
divid
two
fraction
either
left
untreat
incub
microbead
miltenyi
catalogu
hour
constant
nutat
microbead
pass
retain
column
miltenyi
catalogu
flow
harvest
virion
particl
contain
nondeplet
fraction
purifi
ultracentrifug
sucros
normal
exort
activ
compar
wb
infect
analys
antibodi
use
wb
purchas
becton
dickinson
catalogu
silenc
endogen
ifitm
obtain
stabl
transduct
recipi
cell
lentivir
vector
describ
lentivir
vector
produc
cotransfect
cell
dna
code
structur
protein
gagpol
envelop
plu
viral
genom
bear
cassett
two
target
sequenc
per
ifitm
use
total
six
cotransfect
cell
plate
obtain
singl
viral
prepar
either
control
ifitm
silenc
virion
particl
purifi
describ
normal
exogenousrevers
transcript
assay
normal
amount
lentivir
vector
use
target
cell
obtain
silenc
case
hela
cell
activ
pbl
cell
challeng
multipl
infect
compris
moi
infecti
titer
viral
vector
establish
upon
comparison
standard
known
infect
three
round
viral
challeng
everi
twentyfour
hour
cell
briefli
select
puromycin
two
day
enrich
cell
cultur
effect
silenc
cell
case
macrophag
cell
challeng
moi
code
virus
presenc
moiequival
virionlik
particl
bear
sivmac
vpx
vlpsvpx
trick
allow
effici
transduct
myeloid
cell
thank
report
abil
vpx
remov
restrict
factor
target
sequenc
use
publish
laboratori
report
uniqu
eas
luciferas
agctcccgtgaattggaatcc
atctgtgacagtctaccatatt
cccatattatgttacagataat
accagcctcccaactacgagat
acccgatgtccaccgtgatcca
acccgacgtccaccgtgatcca
acccccaactatgagatgctca
virion
particl
produc
presenc
absenc
differ
ifitm
normal
describ
supplementari
fig
tabl
remain
virus
normal
qpcr
rtqpcr
use
genom
specif
primer
list
tabl
infect
carri
normal
viral
prepar
use
differ
virusspecif
assay
detail
supplementari
fig
compar
overview
infecti
viral
titer
obtain
use
present
supplementari
fig
infect
singl
round
compet
sivmac
mlv
mpmv
ebv
aav
viral
particl
measur
cell
b
lymphocyt
raji
cell
ebv
fac
three
day
infect
approxim
singl
cycl
infect
infect
replic
compet
wnv
vsv
mev
rvfv
virus
carri
high
moi
percentag
infect
cell
measur
shortest
detect
time
point
fac
avoid
multipl
cycl
infect
hour
post
infect
respect
moi
compris
case
accumul
viral
code
gfp
measur
target
cell
except
rvfv
nss
measur
spread
infect
carri
low
moi
vsv
ebov
mev
wnv
depend
viru
progress
infect
monitor
accumul
gfpposit
cell
time
fac
focu
form
assay
ffa
tissu
cultur
infecti
dose
assay
use
case
hcv
dugv
mopv
case
ebov
respect
formvarcarbonco
nickel
grid
deposit
drop
purifi
unfix
virus
produc
presenc
absenc
flagtag
five
minut
prior
sequenti
incub
antiflag
antibodi
sigma
stloui
mo
follow
incub
goldconjug
nm
goatantirabbit
igg
aurion
wageningen
netherland
fixat
glutaraldehyd
neg
stain
perform
use
uranyl
acet
agar
scientif
stanst
uk
follow
transmiss
electron
microscop
analys
jeol
tokyo
japan
